These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 10640351)
21. Amino-terminal residues 1-45 of the Escherichia coli pyruvate dehydrogenase complex E1 subunit interact with the E2 subunit and are required for activity of the complex but not for reductive acetylation of the E2 subunit. Park YH; Wei W; Zhou L; Nemeria N; Jordan F Biochemistry; 2004 Nov; 43(44):14037-46. PubMed ID: 15518552 [TBL] [Abstract][Full Text] [Related]
22. Genetic selection for and molecular dynamic modeling of a protein transmembrane domain multimerization motif from a random Escherichia coli genomic library. Leeds JA; Boyd D; Huber DR; Sonoda GK; Luu HT; Engelman DM; Beckwith J J Mol Biol; 2001 Oct; 313(1):181-95. PubMed ID: 11601855 [TBL] [Abstract][Full Text] [Related]
23. Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding. Herberg FW; Maleszka A; Eide T; Vossebein L; Tasken K J Mol Biol; 2000 Apr; 298(2):329-39. PubMed ID: 10764601 [TBL] [Abstract][Full Text] [Related]
24. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells. Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704 [TBL] [Abstract][Full Text] [Related]
25. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin. Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963 [TBL] [Abstract][Full Text] [Related]
26. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation. Haelens A; Verrijdt G; Callewaert L; Christiaens V; Schauwaers K; Peeters B; Rombauts W; Claessens F Biochem J; 2003 Jan; 369(Pt 1):141-51. PubMed ID: 12350223 [TBL] [Abstract][Full Text] [Related]
27. Assay development for high throughput screening of p21(Waf1/Cip1) protein expression in intact cells using fluorometric microvolume assay technology. Grand-Perret T; Cik M; Arts J; Vander Borght A; Ercken M; Valckx A; Vermeesen A; Roevens R; Janicot M Drugs Exp Clin Res; 2004; 30(3):89-98. PubMed ID: 15366785 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of a dimerization-arm-mimetic peptide on EGF receptor activation. Mizuguchi T; Uchimura H; Kakizawa T; Kimura T; Yokoyama S; Kiso Y; Saito K Bioorg Med Chem Lett; 2009 Jun; 19(12):3279-82. PubMed ID: 19419869 [TBL] [Abstract][Full Text] [Related]
29. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor. Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530 [TBL] [Abstract][Full Text] [Related]
30. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression. Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594 [TBL] [Abstract][Full Text] [Related]
31. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation. Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971 [TBL] [Abstract][Full Text] [Related]
32. EPO receptor-mediated ERK kinase and NF-kappaB activation in erythropoietin-promoted differentiation of astrocytes. Lee SM; Nguyen TH; Park MH; Kim KS; Cho KJ; Moon DC; Kim HY; Yoon DY; Hong JT Biochem Biophys Res Commun; 2004 Aug; 320(4):1087-95. PubMed ID: 15249201 [TBL] [Abstract][Full Text] [Related]
35. Plasminogen activator inhibitor-1 fused with erythropoietin (EPO) mimetic peptide (EMP) enhances the EPO activity of EMP. Kuai L; Wu C; Qiu Q; Zhang J; Zhou A; Wang S; Zhang H; Song Q; Liao S; Han Y; Liu J; Ma Z J Pept Res; 2000 Aug; 56(2):59-62. PubMed ID: 10961539 [TBL] [Abstract][Full Text] [Related]
36. Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site. Naranda T; Wong K; Kaufman RI; Goldstein A; Olsson L Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7569-74. PubMed ID: 10377456 [TBL] [Abstract][Full Text] [Related]
37. The structure, organization, activation and plasticity of the erythropoietin receptor. Wilson IA; Jolliffe LK Curr Opin Struct Biol; 1999 Dec; 9(6):696-704. PubMed ID: 10607675 [TBL] [Abstract][Full Text] [Related]